前收市價 | 53.81 |
開市 | 54.35 |
買盤 | 55.05 x 400 |
賣出價 | 55.14 x 400 |
今日波幅 | 54.00 - 55.29 |
52 週波幅 | 37.55 - 91.10 |
成交量 | |
平均成交量 | 1,722,095 |
市值 | 4.675B |
Beta 值 (5 年,每月) | 1.74 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.94 |
業績公佈日 | 2024年2月21日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 85.88 |
It pays to develop novel medicines for life-threatening illnesses.
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $53.91, moving +0.34% from the previous trading session.